| Factor Information | |
|---|---|
| Data ID | 3884 |
| Factor | death after operation of different CHD(Pp/Ps>0.75) |
| Description | 5 out of 9 patients with TAPVD, 19 out of 77 with PDA and 3 out of 154 with ASD were associated with severe pulmonary hypertension of Pp/Ps greater than 0.75. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To compare the motality rate between different severity of PAH. |
| Conclusion | 5 out of 9 patients with TAPVD, 19 out of 77 with PDA and 3 out of 154 with ASD were associated with severe pulmonary hypertension of Pp/Ps greater than 0.75. Operative results were poor in TAPVD. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 725 |
| CHD Type | isolated CHD |
| CHD Subtype | PDA/TAPVD |
| Reference | |
|---|---|
| PMID | 950730 |
| Year | 1976 |
| Title | Total correction for congenital heart disease associated with severe pulmonary hypertension. |
| Sample | ||
|---|---|---|
| Population | N/A | |
| Source | patients | |
| Region | Kyoto, Japan | |
| Method | observational study | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | TAPVD(Treatment) | PDA(Control) |
| Number | 3(total:5) | 0(total:19) |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.6 | 0 |
